<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 11308133
Antinuclear antibodies are used in the diagnosis and evaluation of patients with connective tissue diseases. The study of antinuclear antibodies has also fundamentally expanded our understanding of nuclear anatomy and function. This article reviews the clinically relevant antinuclear antibodies and their disease associations. Developing an understanding of the utilities and limitations of antinuclear antibodies is essential to providing the expert diagnoses prognoses, and care expected of a dermatologist.
Scleroderma, Systemic, Antibodies, Antinuclear, Lupus Erythematosus, Cutaneous, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Connective Tissue Diseases, Skin Diseases, Autoantibodies
Scleroderma, Systemic, Antibodies, Antinuclear, Lupus Erythematosus, Cutaneous, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Connective Tissue Diseases, Skin Diseases, Autoantibodies
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |